Literature DB >> 29233640

Rapid Response to Larotrectinib (LOXO-101) in an Adult Chemotherapy-Naive Patients With Advanced Triple-Negative Secretory Breast Cancer Expressing ETV6-NTRK3 Fusion.

Yosef Landman1, Maya Ilouze1, Simon Wein1, Victoria Neiman1, Rinat Yerushalmi1, Maxim Yakimov2, Nora Ku3, Alexa B Schrock4, Siraj Ali4, Nir Peled5.   

Abstract

Entities:  

Keywords:  NGS; NTRK3; SBC; TNBC; Targeted therapy

Mesh：

Substances：

Year:  2017        PMID： 29233640     DOI： 10.1016/j.clbc.2017.11.017

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN： 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  8 in total

Review 1.  TRK Inhibition: A New Tumor-Agnostic Treatment Strategy.

Authors:  Shivaani Kummar; Ulrik N Lassen
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

2.  Applicability of pan-TRK immunohistochemistry for identification of NTRK fusions in lung carcinoma.

Authors:  Simon Strohmeier; Iva Brcic; Helmut Popper; Bernadette Liegl-Atzwanger; Jörg Lindenmann; Luka Brcic
Journal:  Sci Rep       Date:  2021-05-07       Impact factor: 4.379

Review 3.  Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance.

Authors:  Suet Kee Loo; Megan E Yates; Sichun Yang; Steffi Oesterreich; Adrian V Lee; Xiao-Song Wang
Journal:  Genes Chromosomes Cancer       Date:  2022-02-17       Impact factor: 5.006

Review 4.  Detection of Tumor NTRK Gene Fusions to Identify Patients Who May Benefit from Tyrosine Kinase (TRK) Inhibitor Therapy.

Authors:  Susan J Hsiao; Ahmet Zehir; Anthony N Sireci; Dara L Aisner
Journal:  J Mol Diagn       Date:  2019-05-07       Impact factor: 5.568

5.  Case Report: Adult NTRK-Rearranged Spindle Cell Neoplasm: Early Tumor Shrinkage in a Case With Bone and Visceral Metastases Treated With Targeted Therapy.

Authors:  Federica Recine; Alessandro De Vita; Valentina Fausti; Federica Pieri; Alberto Bongiovanni; Eugenia Franchini; Roberto Casadei; Maria Cristina Falasconi; Devil Oboldi; Federica Matteucci; Maria Caterina Pallotti; Laura Mercatali; Nada Riva; Lorena Gurrieri; Silvia Vanni; Chiara Liverani; Giacomo Miserocchi; Chiara Spadazzi; Claudia Cocchi; Toni Ibrahim
Journal:  Front Oncol       Date:  2022-01-07       Impact factor: 6.244

Review 6.  Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review.

Authors:  Jing Lian; Li-Xia Wang; Jiang-Hong Guo; Peng Bu; Yan-Feng Xi; Ke-Ming Yun
Journal:  Diagn Pathol       Date:  2021-10-10       Impact factor: 2.644

Review 7.  The oncogenic fusion landscape in pediatric CNS neoplasms.

Authors:  Mieke Roosen; Zelda Odé; Jens Bunt; Marcel Kool
Journal:  Acta Neuropathol       Date:  2022-02-15       Impact factor: 15.887

8.  Regression of ETV6-NTRK3 Infantile Glioblastoma After First-Line Treatment With Larotrectinib.

Authors:  Musa Alharbi; Nahla Ali Mobark; Ali Abdullah O Balbaid; Fatmah A Alanazi; Wael Abdel Rahman Aljabarat; Eman A Bakhsh; Shakti H Ramkissoon; Malak Abedalthagafi
Journal:  JCO Precis Oncol       Date:  2020-06-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.